What an Indian pharma giant’s new drug find can gain the world’s obesity fight

Trust Sun Pharma boss Dilip Shanghvi to be at the cutting-edge of research. After building a band of specialty drugs that exceeds a billion dollars in sales globally, Shanghvi has placed his bets on weight-loss or anti-obesity drugs, a field that has sent pharmaceutical companies across the world in a hot pursuit. Riding on blockbusters such as Ozempic, Wegovy, and Zepbound, their makers Novo Nordisk and Eli Lilly are ranked the most valuable